Premium
The prognosis of systemic sclerosis
Author(s) -
ROWELL N.R.
Publication year - 1976
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.1976.tb15535.x
Subject(s) - sclerodactyly , medicine , calcinosis , telangiectasia , scleroderma (fungus) , dermatology , progressive systemic sclerosis , systemic therapy , systemic scleroderma , systemic disease , pathology , disease , raynaud disease , calcification , cancer , breast cancer , inoculation , dermatomyositis
SUMMARY Eighty‐four patients with systemic sclerosis have been investigated and observed at intervals for up to 15 years. The prognosis is worse in males than in females although in any individual case the clinical course is unpredictable. Those patients with the combination of calcinosis, Raynaud's phenomehon, sclerodactyly and telangiectasia have the same degree of systemic involvement and the same prognosis as other patients with systemic sclerosis, and the term ‘CRST syndrome’ should be abandoned.